Showing results (121-130 of 414) with videos related to

Sort By:
Pageof 42
Blood|July 15, 1994
Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencingM Kneba, I Bolz, B Linke, et al.
Leukemia|March 1, 1990
Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapyW Hiddemann, W R Martin, C M Sauerland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers?D Hauke, S Reiter-Theil, E Hoster, et al.
Onkologie|February 1, 1990
Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for ChemotherapyG Maschmeyer, H Link, W Hiddemann, et al.
Seminars in Diagnostic Pathology|August 1, 1984
New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitationsA Roessner, W Mellin, W Hiddemann, et al.
Pathology, Research and Practice|December 1, 1985
Biological characterization of human bone tumors. VII. Detection of malignancy in a giant cell tumor of bone by flow cytometric DNA-analysisW Mellin, A Roessner, E Grundmann, et al.
Leukemia|April 1, 1997
Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blastsC Reuter, E Schleyer, C Rolf, et al.
European Journal of Clinical Pharmacology|October 16, 2001
Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patientsB Erdlenbruch, M Nier, W Kern, et al.
Cancer|January 1, 1997
High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II studyW Kern, E Schleyer, M Unterhalt, et al.
Blood|February 1, 1982
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemiaW Hiddemann, B D Clarkson, T Büchner, et al.
Pageof 42